Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Announce Third Quarter Financial Results on Wednesday, November 8

Key Takeaway: electroCore, Inc. is set to announce its third quarter financial results on November 8, 2023, after market close. The company, known for its bioelectronic medicine technology, will host a conference call at 4:30 PM EST to discuss the results and address any investor questions. This announcement highlights the company's ongoing commitment to transparency and investor communication.
Price reaction · baseline $5.59 (2023-10-06 close) · 1 other ECOR headline(s) in the window, move may be shared
day 0 close
+1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore will be announcing its third quarter financial results soon.
  • The company is focused on improving health through innovative technology.
  • A conference call will allow for engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the third quarter ended September 30, 2023, after the close of the market on Wednesday, November 8, 2023. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
Wednesday, November 8, 2023, 4:30 PM EST
Domestic: 877-407-8835
International: located here
Conference ID: 13739201
Webcast: electroCore Earnings Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When will electroCore report its Q3 financial results?

electroCore will report its Q3 financial results on November 8, 2023.

What time is the electroCore conference call on November 8?

The conference call is scheduled for 4:30 PM EST on November 8, 2023.

How can I listen to the electroCore earnings webcast?

You can listen to the webcast via the electroCore Earnings Webcast link.

What technology does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation (nVNS) technology.

What is the purpose of electroCore's nVNS technology?

nVNS technology aims to manage medical conditions and enhance wellbeing.

Last updated: Oct 9, 2023